95-3626. Manufacturer of Controlled Substances; Notice of Registration  

  • [Federal Register Volume 60, Number 30 (Tuesday, February 14, 1995)]
    [Notices]
    [Pages 8413-8414]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 95-3626]
    
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF JUSTICE
    
    Drug Enforcement Administration
    
    
    Manufacturer of Controlled Substances; Notice of Registration
    
        By Notice dated July 19, 1994, and published in the Federal 
    Register on July 28, 1994 (59 FR 38492), Dupont Pharmaceuticals, The 
    Dupont Merck Pharmaceutical Company, 1000 Stewart Avenue, Garden City, 
    New York 11530, made application to the Drug Enforcement Administration 
    (DEA) to be registered as a bulk manufacturer of the basic classes of 
    controlled substances listed below:
    
    ------------------------------------------------------------------------
                                Drug                               Schedule 
    ------------------------------------------------------------------------
    Oxycodone (9143)...........................................  II         
    Hydrocodone (9193).........................................  II         
    Oxymorphone (9652).........................................  II         
    ------------------------------------------------------------------------
    
        No comments or objections have been received. Therefore, pursuant 
    to Section [[Page 8414]] 303 of the Comprehensive Drug Abuse Prevention 
    and Control Act of 1970 and Title 21, Code of Federal Regulations, 
    Section 1301.54(e), the Deputy Assistant Administrator, Office of 
    Diversion Control, hereby orders that the application submitted by the 
    above firm for registration as a bulk manufacturer of the basic classes 
    of controlled substances listed above is granted.
    
        Dated: February 6, 1995.
    Gene R. Haislip,
    Deputy Assistant Administrator, Office of Diversion Control, Drug 
    Enforcement Administration.
    [FR Doc. 95-3626 Filed 2-13-95; 8:45 am]
    BILLING CODE 4410-09-M
    
    

Document Information

Published:
02/14/1995
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
95-3626
Pages:
8413-8414 (2 pages)
PDF File:
95-3626.pdf